financetom
Business
financetom
/
Business
/
Sprout Social Insider Sold Shares Worth $1,252,800, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sprout Social Insider Sold Shares Worth $1,252,800, According to a Recent SEC Filing
Apr 8, 2024 2:56 PM

05:34 PM EDT, 04/08/2024 (MT Newswires) -- Aaron Edward Frederick Rankin, 10% Owner, Director, on April 04, 2024, sold 22,000 shares in Sprout Social ( SPT ) for $1,252,800. Following the Form 4 filing with the SEC, Rankin has control over a total of 44,487 shares of the company, with 44,487 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1517375/000151737524000060/xslF345X03/wk-form4_1712611754.xml

Price: 56.06, Change: -1.14, Percent Change: -1.99

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Surmodics Says Upon Termination Of Merger Under Specified Circumstances, Co Would Be Required To Pay Termination Fee Of $20.4 Million To Bce Parent Llc
BRIEF-Surmodics Says Upon Termination Of Merger Under Specified Circumstances, Co Would Be Required To Pay Termination Fee Of $20.4 Million To Bce Parent Llc
May 29, 2024
May 29 (Reuters) - Surmodics Inc ( SRDX ): * SURMODICS SAYS UPON TERMINATION OF MERGER UNDER SPECIFIED CIRCUMSTANCES, CO WOULD BE REQUIRED TO PAY TERMINATION FEE OF $20.4 MILLION TO BCE PARENT LLC * SURMODICS ( SRDX ) - UPON TERMINATION OF MERGER UNDER SPECIFIED CIRCUMSTANCES, BCE PARENT WOULD BE REQUIRED TO PAY REVERSE TERMINATION FEE OF $50.2 MILLION...
BRIEF-EQT Exeter To Acquire Five-Million-Square-Foot Industrial Assemblage From Prologis
BRIEF-EQT Exeter To Acquire Five-Million-Square-Foot Industrial Assemblage From Prologis
May 29, 2024
May 29 (Reuters) - EQT AB: * EQT EXETER TO ACQUIRE FIVE-MILLION-SQUARE-FOOT INDUSTRIAL ASSEMBLAGE FROM PROLOGIS Source text for Eikon: Further company coverage: ...
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints
May 29, 2024
09:00 AM EDT, 05/29/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Wednesday that topline results from a phase 3 trial evaluating seltorexant as an adjunctive treatment to baseline antidepressants in adult and elderly patients with major depressive disorder met all primary and secondary endpoints. The company said seltorexant demonstrated a statistically significant and clinically meaningful improvement in...
Stereotaxis' Robotic Navigation System Used to Treat First Patients
Stereotaxis' Robotic Navigation System Used to Treat First Patients
May 29, 2024
09:06 AM EDT, 05/29/2024 (MT Newswires) -- Stereotaxis ( STXS ) said Wednesday its medical robotic navigation platform was successfully used in the first successful treatment of heart rhythm patients. Philadelphia's Penn Presbyterian Medical Center used Stereotaxis' ( STXS ) Genesis Robotic Magnetic Navigation System for cardiac ablation, a procedure to treat irregular heart rhythms ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved